Veronica Jordan, Ph.D.
Since 2007, Veronica Jordan has served as an independent consultant to healthcare companies and contract research organizations and as Managing Director of Golden Seeds, an angel investor network. She was previously CEO and President of Medelle Corporation, a private medical device company, and held various executive roles at PAREXEL International during her 14 years on the company’s management team. Veronica has been a member of the Board of Directors of Vermillion, Inc. since 2014 and currently serves as Chair of the Compensation Committee and a member of the Audit Committee. From 2006 to 2016, she was a Director of Albany Molecular Research, Inc. Veronica earned a B.A. in biochemistry from Cambridge University and a Ph.D. in biochemistry and cell biology from Oxford University.